Greater improvement in CHD risk factors for combined intervention versus either alone.
Phase 3 studies next to assess longer-term/clinical outcomes, safety.
Adding sulfonylurea or metformin to insulin decreases HbA1c about 1
Case report describes treatment of female patient who attempted suicide with metformin overdose.
Greater drop in HbA1c with DPP4i added to alpha glucosidase inhibitor, with no increase in weight.
Similar findings among individuals with diabetes able to achieve normoglycemia.
Primary aim of diagetes management is lowering blood glucose or glycated hemoglobin (HbA1c) concentrations.
Second-line treatment often initiated without evidence of recommended use of first-line treatment.
Instead, sensor is implanted below skin in patients with diabetes.
Study of Medicare patients shows overtreatment for diabetes is rarely deintensified.
The results demonstrated a tendency for a decrease in LDL-C level at 24 weeks in the ANA group, and improvement was mediated through the suppression of apoB-100 synthesis.
Administration of exenatide in patients with type 2 diabetes at a wide range of cardiovascular risk appeared not to cause an increase in their overall cardiovascular risk.
This synopsis focuses on recommendations from the 2017 Standards of Care about monitoring and pharmacologic approaches to glycemic management for type 1 diabetes.
The researchers found that, compared with placebo, diacerein reduced HbA1c by 0.35% in the intention-to-treat analysis and by 0.41% in the per-protocol analysis.
Among pregnant women with FIR at 25, 30, and 36 weeks, the ratio of soluble fms-like tyrosine kinase 1 to placental growth factor was significantly higher.
Frequent consumption of alcohol is associated with the lowest risk of diabetes.
After 11 pounds gained, the risk of diabetes went up 31%, hypertension 14%, and cardiovascular disease 8%.
Liraglutide-treated patients were 22% less likely than placebo recipients to experience a composite outcome of renal events.
The addition of V/S ratio to age, eGFR, BNP, antiplatelet agents, and HbA1c significantly improved classification performance for CVD.
Meta-analysis of studies conducted around the world found that men with diabetes have more than 3.5 times increased risk for erectile dysfunction.
The researchers found that women who experienced premature menopause were 3.7 times more likely to develop diabetes.
The cardiac biomarker data provide support for the beneficial cardiovascular effect of sodium glucose co-transporter 2 inhibitors in T2DM.
Diabetes patients pursuing lifestyle interventions had a significantly increased risk of frailty fracture compared to diabetes support and education intervention patients.
Diabetes was seventh leading cause of death in 2015 in United States, according to report.
Addition of CCTA-detected obstructive coronary artery disease to risk factors ups prediction of MACE.
The rates of overall symptomatic hypoglycemia for insulin degludec vs insulin glargine were 185.6 vs 265.4 episodes per 100 PYEs.
Patients who achieved SVR had a greater drop in HbA1c associated with antiviral treatment than those who sustained treatment failure.
Between 2002 and 2013, heart failure hospitalizations declined by 30.8% nationwide, and continue to drop.
Therapeutic inertia was seen in 18.1% of the 12,730 patients with HbA1c of ≥8% at baseline or during follow-up.
The researchers found that 57% of participants expressed interest in learning their secondary germline findings, while 29% and 14%, respectively, were equivocal or disinterested.
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)